Doctor Eli Roth
University of Cincinnati, Cincinnati (United States of America)
Assessment of absolute reductions in LDL-C associated with alirocumab therapy: results from across the Phase 3 ODYSSEY programme
Event: ESC Congress 2017
Topic: Lipids (Epidemiology and Prevention)
Session: Lipids
ESC 365 is supported by
